Skip to main content

BARCLAYS PLC

Position in NBIX — Neurocrine Biosciences Inc

CIK 312069 LONDON, X0

Position in NBIX

as of Jun 30, 2026 · filed Aug 14, 2026
Position Value
$54,742,970
+$22,600,520 QoQ
Shares Held
324,807
+33.1% QoQ
Ownership
0.320%
of shares outstanding
% of Portfolio
0.02%
of 13F equity value
Holder Rank
#56
of 768 holders
Holding Since
Mar 2020
14 quarters on record
Voting authority Sole 92% Shared 0% None 8%

Common Shares in NBIX Over Time

Shares Held

Position Value (USD)

Derivatives in NBIX

reported options exposure · as of Jun 30, 2021
CallValue
$0
CallShares
0
PutValue
$10,588,416
PutShares
108,800

Notional value of option positions as reported on Form 13F. Calls and puts are disclosed separately and do not net against the common-share stake above.

Position in Drug Manufacturers - Specialty & Generic

Healthcare · as of Jun 30, 2026

BARCLAYS PLC holds $487,957,812 across 61 Drug Manufacturers - Specialty & Generic names. NBIX ranks #2 (11.2% of the industry book) .

# Ticker Company Shares Value (USD) Open
2 NBIX
Neurocrine Biosciences Inc
This page
324,807 $54,742,970

All Filings in NBIX

Export CSV
19 filing rows on record
Report Date Value (USD) Shares
2026-06-30 $54,742,970 324,807
2026-03-31 $32,142,450 243,984
2025-12-31 $35,775,338 252,241
2022-09-30 $15,570,703 146,603
2022-06-30 $11,577,308 118,766
2022-03-31 $10,754,154 114,711
2021-12-31 $11,275,399 132,387
2021-09-30 $14,903,165 155,387
2021-06-30 $10,588,416 108,800
2021-06-30 $19,756,346 203,004
2021-03-31 $7,335,371 75,428
2020-12-31 $3,724,249 38,855
2020-09-30 $6,921,498 71,979
2020-09-30 $134,624 1,400
2020-06-30 $170,800 1,400
2020-06-30 $5,312,856 43,548
2020-03-31 $1,869,480 21,600
2020-03-31 $1,081,875 12,500
2020-03-31 $2,682,183 30,990